Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: Results of CALGB Protocol 39803

Michael T. Jaklitsch*, Lin Gu, Todd Demmy, David H. Harpole, Thomas A. D'Amico, Robert J. McKenna, Mark J. Krasna, Leslie J. Kohman, Scott J. Swanson, Malcolm M. Decamp, Xiaofei Wang, Susan Barry, David J. Sugarbaker

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint Dive into the research topics of 'Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: Results of CALGB Protocol 39803'. Together they form a unique fingerprint.

Medicine & Life Sciences